Evidence map›Paper›PMID 34858321›Full record

ArticleFrontiers in endocrinology2021

Case Report: A Case of Moyamoya Syndrome Associated With Multiple Endocrine Neoplasia Type 2A.

Fumihiro Matano, Yasuo Murai, Atsushi Watanabe, Kazutaka Shirokane, Takehito Igarashi, Kazuo Shimizu, Takashi Shimada, Akio Morita

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fumihiro MatanoDepartment of Neurosurgery, Nippon Medical School, Tokyo, Japan.
Yasuo MuraiDepartment of Neurosurgery, Nippon Medical School, Tokyo, Japan.
Atsushi WatanabeDivision of Clinical Genetics, 3 Support Center for Genetic Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Kazutaka ShirokaneDepartment of Neurosurgery, Nippon Medical School, Tokyo, Japan.
Takehito IgarashiDepartment of Endocrine Surgery, Nippon Medical School, Tokyo, Japan.
Kazuo ShimizuDepartment of Endocrine Surgery, Nippon Medical School, Tokyo, Japan.
Takashi ShimadaDivision of Clinical Genetics, 3 Support Center for Genetic Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Akio MoritaDepartment of Neurosurgery, Nippon Medical School, Tokyo, Japan.
Nippon Medical School · JPKanazawa University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To the best of our knowledge, we report a case of MEN2A complicated by moyamoya syndrome. A 52-year-old woman presented with vertigo. Magnetic resonance angiography (MRA) revealed bilateral supraclinoid stenosis of the internal carotid artery and abnormal moyamoya-like vessels around the basal ganglia. She had a heterozygous variant of

Indexed as

MutationAdenosine TriphosphatasesAdrenal Gland NeoplasmsCarcinoma, NeuroendocrineFemaleHumansMaleMiddle AgedMoyamoya DiseaseMultiple Endocrine Neoplasia Type 2aPedigreePheochromocytomaThyroid NeoplasmsUbiquitin-Protein LigasesAdenosine TriphosphatasesRNF213 protein, humanUbiquitin-Protein LigasesMEN2Amoyamoya syndromepheochromocytomaRET geneRNF-213

Identifiers

PMID34858321
PMCPMC8632216
OpenAlexW3212568781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.